South Texas Accelerated Research Therapeutics (START)

Madrid 28040

1 studies enrolling now · 1 studies all time

What they study most

Astrocytoma, Grade III, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Studies at this site

• A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — Recruiting now